Placenta-derived extracellular vesicles induce preeclampsia in mouse models.
Preeclampsia is a pregnancy-induced condition that impairs mother's health and results in pregnancy termination or premature delivery. Elevated levels of placenta-derived extracellular vesicles in the circulation have been consistently associated with preeclampsia, but whether placenta-derived extracellular vesicles induce preeclampsia or are merely the product of preeclampsia is not known. Guided by a small cohort study of preeclampsia patients, we examined the impact of placenta-derived extracellular vesicles on the pathogenesis of preeclampsia in mouse models. We found that placenta-derived extracellular vesicles were detected in pregnant C56BL/6J mice with a peak level of 3.8+/-0.9x107/ml in 17-18 days post-coitum. However, these pregnant mice developed hypertension and proteinuria only after being infused with these vesicles purified from injured placenta. These injured placenta-released extracellular vesicles disrupted the endothelial integrity and induced vasoconstriction. Enhancing the clearance of extracellular vesicles prevented the development of the extracellular vesicle-induced preeclampsia in mice. Our results demonstrate a causal role of placenta-derived extracellular vesicles in preeclampsia and identify microvesicle clearance as a new therapeutic target for the treatment of this pregnancy-associated complication.